Elanco Animal Health (ELAN) Competitors

BeOne Medicines (NASDAQ:ONC) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

Is ONC or ELAN more profitable?

Elanco Animal Health has a net margin of 8.43% compared to BeOne Medicines' net margin of -9.40%. Elanco Animal Health's return on equity of 7.54% beat BeOne Medicines' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BeOne Medicines	-9.40%	-7.55%	-4.42%
Elanco Animal Health	8.43%	7.54%	3.57%

Which has higher earnings & valuation, ONC or ELAN?

Elanco Animal Health has higher revenue and earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BeOne Medicines	$3.81B	7.31	-$644.79M	-$3.72	-68.27
Elanco Animal Health	$4.44B	1.66	$338M	$0.74	20.06

Which has more risk and volatility, ONC or ELAN?

BeOne Medicines has a beta of 0.28, indicating that its share price is 72% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500.

Do institutionals and insiders hold more shares of ONC or ELAN?

48.6% of BeOne Medicines shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 6.6% of BeOne Medicines shares are owned by insiders. Comparatively, 0.9% of Elanco Animal Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Do analysts recommend ONC or ELAN?

BeOne Medicines currently has a consensus price target of $320.67, suggesting a potential upside of 26.26%. Elanco Animal Health has a consensus price target of $15.33, suggesting a potential upside of 3.29%. Given BeOne Medicines' stronger consensus rating and higher possible upside, analysts clearly believe BeOne Medicines is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BeOne Medicines	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
Elanco Animal Health	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the media favor ONC or ELAN?

In the previous week, Elanco Animal Health had 5 more articles in the media than BeOne Medicines. MarketBeat recorded 8 mentions for Elanco Animal Health and 3 mentions for BeOne Medicines. BeOne Medicines' average media sentiment score of 0.51 beat Elanco Animal Health's score of 0.43 indicating that BeOne Medicines is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BeOne Medicines	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elanco Animal Health	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Elanco Animal Health beats BeOne Medicines on 10 of the 16 factors compared between the two stocks.